Those with kidney disease require careful monitoring, as GLP-1 effects on dehydration and renal perfusion may worsen declining kidney function
Adults with a BMI of 30 or higher or a BMI of 27 or higher who have one or more weight-related medical conditions are good candidates for semaglutide
Your plan here addresses visceral fat, insulin resistance, and body composition directly
GLP-1 acts on the brain to induce feelings of satiety, thus reducing appetite and leading to weight loss
The weight loss of the low dose (0.03 mg/kg) group, medium dose (0.1 mg/kg) group, and high dose (0.33 mg/kg) group were about 2g, 4g, and 1g (8 weeks)
The most commonly used medical skin whitening approach involves glutathione therapy